![Fiona MacLaughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fiona MacLaughlin
Directeur/Membre du Conseil chez
Mestag Therapeutics Ltd.
Profil
Fiona MacLaughlin is the founder of Arrakis Therapeutics, Inc., founded in 2015.
Current jobs include Non-Executive Director at Pulmocide Ltd. since 2020, Non-Executive Director at Syndesi Therapeutics SA since 2020, Non-Executive Director at Calypso Biotech BV since 2020, Non-Executive Director at Mestag Therapeutics Ltd. since 2020, Principal at Johnson & Johnson Innovation - JJDC, Inc. since 2020, and Associate at Advent Life Sciences LLP since 2012.
Former jobs include Director at INKEF Capital BV from 2017 to 2020, Director at ONWARD Medical SA, Non-Executive Director at GTX medical BV from 2018 to 2020, Non-Executive Director at NMD Pharma A from 2019 to 2020, Non-Executive Director at iOnctura SA from 2019 to 2020, Associate at Advent Venture Partners LLP from 2012 to 2017, Senior Business Analyst at Wellcome Trust Technology Transfer, Head-Research and Development at Gendel Ltd. from 1997 to 2002, Principal at Odontis Ltd., Head-Strategic Business & Product Development at RepRegen Ltd., Head of Strategic Business Development at RepRegen Ltd. from 2010 to 2012, Strategic Adviser at Tiber Creek Partners LLC from 2010 to 2012, Business Development Manager at The Wellcome Trust Ltd. (Investment Management) from 2005 to 2010, and Advisory Board Member at Apollo Therapeutics No.
2 LLP from 2020 to 2021.
Education includes a doctorate conferred in 1996 and an undergraduate degree conferred in 1992, both from The University of Nottingham.
Postes actifs de Fiona MacLaughlin
| Sociétés | Poste | Début |
|---|---|---|
Calypso Biotech BV
 Calypso Biotech BV BiotechnologyHealth Technology Operates as a biotechnology company focused on the research and development of novel biologics | Directeur/Membre du Conseil | 01/09/2020 |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Directeur/Membre du Conseil | 01/09/2020 |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | 01/05/2020 |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | 01/11/2020 |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Directeur/Membre du Conseil | 01/09/2020 |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Analyste en capital-investissement | 01/03/2012 |
Anciens postes connus de Fiona MacLaughlin
| Sociétés | Poste | Fin |
|---|---|---|
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Consultant / Advisor | 01/06/2021 |
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 31/05/2020 |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Directeur/Membre du Conseil | 01/05/2020 |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Fiona MacLaughlin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Wellcome Trust Technology Transfer
 Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides capital for venture debt and early and later stage capital requirements. | Finance |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gendel Ltd.
 Gendel Ltd. Medical SpecialtiesHealth Technology Provides medical technology devices for cancer tumours treatment | Health Technology |
Odontis Ltd.
 Odontis Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a dental company | Commercial Services |
RepRegen Ltd.
 RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Health Services |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Health Technology |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
Tiber Creek Partners LLC
 Tiber Creek Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides scientific and business counseling to biotechnology & life sciences companies | Commercial Services |
The Wellcome Trust Ltd. (Investment Management)
 The Wellcome Trust Ltd. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous Wellcome-IM controls risk in the portfolio primarily by diversification of assets, and by careful management of the cash flow for their charitable activities so that they are not forced to sell good assets at the wrong time. The majority of the firm’s assets are managed directly by their in-house investment team as well as third-party fund managers – a model that optimizes returns over the long-term. Their funding has come from a wide range of financial assets around the world: publicly listed stocks and shares, private equity, venture capital, property, hedge funds and other investments. | Miscellaneous |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
GTX medical BV
 GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Health Technology |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Health Technology |
Calypso Biotech BV
Calypso Biotech BV BiotechnologyHealth Technology Operates as a biotechnology company focused on the research and development of novel biologics | Health Technology |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
